INTRODUCTION
Evidence from animal studies and clinical trials suggests that angiotensin II, synthesized locally by the action of angiotensin converting enzyme (ACE) within the arterial wall, may be important in the pathogenesis of coronary artery disease. Thus, ACE inhibition can partially restore endothelial function in the arteries of animals fed an atherogenic diet and can also protect against the neointimal proliferative response to endothelial balloon injury. In the SAVE trial, the mortality reduction observed in the group treated with captopril was accompanied by a 25% reduction in the risk of recurrent infarct expansion and remodeling. In the SOLVD studies, ACE inhibition was found to protect against ischemic end-points, patients randomized to enalapril showed a 23% reduction of the risk of unstable angina. Altogether, these studies permit to speculate that the progression of coronary arteries disease might be amenable to modification by ACE inhibition.
Several lines of evidence suggest that an association exists among CVD development, mitochondrial damage and function. It has been shown that CVD patients have increased mitochondrial (mt) DNA damage when compared with healthy controls in both the heart and the aorta (Corral- Atherosclerotic lesions in brain microvessels from Alzheimer's (AD) patients and rodent AD models have significantly more mtDNA deletions and abnormalities (as is the case with the endothelium and perivascular cells), suggesting that the mitochondria within the vascular wall can be the central targets for oxidative stress-induced damage (Aliev et al., 2002) . Chronic ischemia increases both mtDNA deletions in human heart tissue (Corral-Debrinski et al., 1992) and cardiac mitochondrial sensitivity to inhibitors of cellular respiration (Brookes et al., 2001) . Ex vivo studies of rat heart have shown that ischemia reduces myocardial oxidative phosphorilation capacities (Duan et al., 1989) . Using a mouse model for myocardial infarction (MI), it was found that previous MI is associated with increased reactive oxygen species (ROS) and decreased mtDNA copy number, mitochondrial-encoded gene transcripts, and related enzymatic activities (complexes I, III, and IV). However, nuclear-encoded genes (complex II) and citrate synthase are unaffected (Ide et al., 2001) . Cardiotoxic ROS generators increase mtDNA deletions and lipid peroxidation in the myocardial mitochondria; overexpression of mitochondrial antioxidants prevents these effects and increases cardiac tolerance to ischemia (Chen et al., 1998) . Decreased vascular superoxide dismutase-2 (SOD2)-specific activities have been associated with increased exposure to CVD risk factors (Knight-Lozato et al., 2002) and increased susceptibility to ischemia/reperfusion-mediated cardiac damage and resistance to cardiac preconditioning (Asimakis et al., 2002) . Moreover, deficiencies in mitochondrial antioxidants and/or regulatory proteins (uncoupling proteinsUCPs) that modulate mitochondrial oxidant production have been shown to promote the onset of CVD in vivo, consistent with the notion that mitochondrialgenerated oxidants can play a contributory role in atherogenesis (Ballinger et al., 2002; Blanc et al., 2003) . Likewise, overexpression of mitochondrial antioxidants and/or UCPs has been shown to protect against the effects of ischemia/reperfusion and oxidative stress (Chen et al., 1998; Teshima et al., 2003; Bienengraeber et al., 2003) .
Cardiovascular diseases are accompanied by hyperlipidemic states, however, the cellular mechanisms by which exposure to lipids leads to deleterious effects remains unclear. The purpose of this study was to examine the respiratory chain complexes e.g. oxidative capacity of cardiac muscle's mitochondria in the course of hypercholesterolemic atherogenic diet.
MATERIAL AND METHODS

Animals and diets
Male Chinchilla strain rabbits, aged two months at the outset of the study were used. They were randomized into four experimental groups. In the course of twelve weeks of treatment, the rabbits received daily (orally) the following: physiologic saline (control, group A, n=17), atherogenic 2% cholesterol diet (in vivo animal model of atherosclerosis, group B, n=18), atherogenic diet and two hours after that an aqueous solution of captopril (10 mg/kg/day) (Sigma Chem. USA) (group C, n=10) and aqueous solution of captopril only (group D, n=10). The treatment was administered 7 days a week for twelve weeks. The so treated animals were used in further experimental procedures. The investigation conformed to the Guide for the Use and Care of Laboratory Animals published by the US National Institutes of Health (NIH publication No. 85-23, revised 1996).
Measurment of plasma lipids
The total cholesterol, HDL-cholesterol and triglyceride levels in the rabbit plasma were measured by enzymatic "end point" kinetic spectrophotometric method (commercial kit Randox, Great Britain). The value of LDL-cholesterol was calculated using the Fridewald equation. In order to determine the atherogenic risk of lipid origin for all rabbits, two indexes were calculated: LDL/HDLcholresterol and total cholesterol/HDL cholesterol. Cardiovascular risk of lipid origin was calculated for each group of rabbits in two intervals, at the outset and at the end of the treatment.
Mitochondrial preparation
After 12 weeks of treatment the animals were sacrificed and the mitochondrial fraction of the rabbit's heart was isolated by the method of Tyler (1979) . Isolation buffer comprising sucrose (300 mM), Tris (20 mM), and EGTA (10 mM); pH 7.35 at 4 o C. Briefly, the first phase implies tissue homogenization, previously digested by proteases (collagenase, nagarase, Type XXII, EC 3.4.21.62), while differential centrifugation complies the second phase, thus at the end isolated mitochondria of the heart were precipitated at the bottom of the tubes. A subsample of the mitochondrial suspension was saved for protein determination by the method of Lowry et al., using bovine serum albumin as the standard (Lowry et al., 1974) .
Measurement of Respiration Rate
Respiratory parameters of the cardiac mitochondrial population were studied. Oxygen consumption rate by cardiac muscle mitochondria was measured by Clark oxygen electrode (Biological Oxygen Monitor, model 5300, Yellow Springs Instrument Co., USA) in 3 ml Kreb's solution buffered with 10 mmol/L HEPES-NaOH, pH 7.4, at 30 o C. This respiration buffer containes sucrose (300 mM), KCl (50 mM), KH 2 PO 4 (5 mM), MgCl 2 (1 mM), EGTA (5 mM) and Tris (20 mM), pH 7.35. Before use the electrode was calibrated daily (Wise R., 1985) . Mitochondrial oxidative phosphorilation was studied in GMC medium equilibrated with air at 30 o C, and continuously stirred. Glutamate (0.2 mol/L) and malate (0.1 mol/L) were used as substrates (unstimulated, basal respiration rate, state 4, V 4 ). As mitochondria consume oxygen, the electrode plots the curve of oxygen uptake. Mitochondrial respiration was calculated as the decrease in oxygen concentration after the addition of the mitochondrial suspension, assuming an initial oxygen concentration of 224 nmol/L. The typical observation time for respiration measurements was 6 minutes. Five runs were conducted with each mitochondrial sample at a dilution of 1.5 to 2 mg of protein per milliliter. Oxidative activity was expressed as nanomoles of consumed oxygen per minute per mg of protein of thick mitochondrial suspension.
The main characteristic of mitochondrial oxidative capacity is the maximal respiration rate (state 3, V 3 ). To estimate the maximal respiration rate, adenosine diphosphate (ADP, 1 mL of 0.1 M) was added. For mitochondrial coupling, 1 mL of biliary dog serum was added during the same run to test the respiratory response. The mitochondrial uncoupler dinitrophenol (DNP) was added in order to examine the effects on DNP-potentiated rate on mitochondrial respiration. At the end of each measurement, 1 mmol/L NaCN was added, which eliminated all increases in oxygen consumption.
Two indices, ADP/O and Respiratory Control Ratio (RCR=V 3 /V 4 ), were calculated and expressed as the mean of the five replicate runs with each sample.
Drugs and Chemicals
Crystalline cholesterol was purchased from Galenica, USA, and was dissolved in edible oil. Biliary dog serum, glutamate, malate and all other reagents were purchased from Sigma Chemical Co., USA. Table 1 . At the end of treatment both indices were significantly higher in groups B and C than in groups A and D (p<0.01). The cardiac mitochondrial oxygen consumption rates are presented in Table 2 and Figures 3-6 . Unstimulated oxygen consumption rate (State 4) of isolated rabbit's heart mitochondria was significantly lower in rabbits treated with atherogenic diet (group B) and rabbits receiving captopril (group D), than in the controls (Fig. 3) .
Statistical Analysis
The maximum oxygen consumption rate (State 3) was also significantly lower in groups B and D than in group A (Fig. 4) .
However, the ADP/O index of the isolated rabbit's heart mitochondria was significantly lower in group B than in group A, while in group D this index was not significantly different (Fig. 5) . These results may suggest the presence of different mechanisms of oxygen consumption inhibition. Namely, with the used substrates the index was ADP/O=3, or higher. Reduction of this index suggests that in the studied mitochondria, in addition to the process of oxidative phosphorilation, other oxygen consuming processes also take place. Lipid peroxidation is the most commonly recognized one. Reduction of this index in group B coincides with our results that refer to antioxidative capacity of plasma and the determination of nitrite levels (data not presented). Since a fall of ADP/O index was not noted in group D, inhibition of mitochondrial respiration in this group is probably related to the cardioprotective effects of the 12-weeks treatment with ACE inhibitor. Respiratory control ratio (RCR) was not significantly different among the groups. It ranged from 6.07 to 6.28 in all studied rabbits (Fig. 6) . These results indicate the absence of uncoupling in the studied cardiac mitochondria. In group C, captopril added to the atherogenic diet resulted in a significant reduction of the mitochondrial oxygen consumption, compared to atherogenic treatment (Fig. 6) .
DISCUSSION
This study examined whether treatment with an inhibitor of ACE could improve multiple abnormalities in cardiac muscle mitochondria in hypercholesterolemic rabbits. The most significant finding in the current study is that captopril treatment had only limited effects on these abnormalities on oxidative capacity.
Twelve weeks of hyperlipemic atherogenic diet induced multiple abnormalities in the cardiac muscle energy metabolism and mitochondrial oxidative capacity. These abnormalities are: basal oxygen consumption rate without ADP (V 4 ) and the maximal ADP-stimulated respiration rate (V 3 ) showed a marked reduction (quantitative changes); sensibility of mitochondria to ADP (ADP/O) was also reduced (qualitative change) in comparison to the control animals. The effects of ACE inhibitors on myocardial oxygen consumption were studied by Zang et al. (1997) as well, but in a different experimental design. They used isolated micro blood vessels and slices of cardiac muscle, using B2 receptor blockers (HOE 140), nitric oxide (NO) synthase inhibitors (L-NAME and L-NNA), as well as inhibitors of serine proteinase. They have found that respiration in cardiomyocytes was influenced by regulation of the locally produced kinine, mediated by endothelial NO production. In both experimental models, suppression of cardiac mitochondrial respiration was noted under the influence of captopril.
Cardiovascular diseases are often associated with energy deficit, and in many cases this is accompanied by lipid disorders such as hyperlipidemias and obesity (Christoffersen et al. 2003) . However, the nature of such a deficit is still unclear. Since in the heart most of the energy is produced by mitochondria, structural and functional changes derived from, or caused by metabolic disorders, could compromise the energetic status of the organ. In fact, alterations in cellular and mitochondrial membrane composition have been described to affect not only electrical properties of the heart, but also energy production (Pepe, 2002) .
In group B, the basal and maximal respiration rates showed a marked reduction (24% and 26% respectively) evidencing decreased oxygen capacity in tested mitochondria. The simultaneous decrease in these two parameters suggests a diminished amount of mitochondria or a general mitochondrial dysfunction. Such a reduction in the number of mitochondria is frequently associated with aging. Tissues obtained from aged animals and from animals with developed atherosclerosis, not only showed a reduced number of mitochondria, but also display changes in mitochondrial structure, such as swelling, shortening of the cristae and matrix vacuolization (Feder et al. 1993 ). These changes were associated to an increased generation of superoxide anion and hydrogen peroxide, and also to a decline of energy production.
The ADP/O index was significantly lower in group B (2.07) than in group A (3.24). Reduction of this index suggests that in the studied mitochondria, in addition to the process of oxidative phosphorilation, other oxygen consuming processes also take place, lipid peroxidation being the most commonly recognized one (Droge, 2002; Mital et al., 2002) . Reduction of this index in group B also coincides with our results that refer to the antioxidative capacity of plasma and the determined nitrite levels (Kojic, 2002) . The fall of this index is probably related to irreversible inhibition of respiration due to enhanced peroxinitrite formation (Ballinger et al., 2004) . There is, however, evidence that at moderate concentrations superoxide anion and related reactive oxygen species play an important role as regulatory mediators in signaling processes (reestablish redox homeostasis) (Ballinger et al., 2002) .
Respiratory control ratio (RCR) was not significantly different among the groups. It ranged from 6.07 to 6.28 in all studied rabbits. These results indicate the absence of uncoupling in the studied mitochondria of the rabbit heart. These results may contribute to the elucidation of complex relationship in the course of mitochondrial respiration inhibition in physiological (cardioprotective) and patophysiological (atherogenesis) conditions.
In conclusion, in line with our previous work, in the present study, twelve weeks treatment by hypercholesterolemic, atherogenic diet led to quantitative changes in mitochondrial function. Hyperlipecholesterolemia also induced qualitative changes in mitochondrial oxidative capacity, namely decreased ADP sensitivity. These multiple abnormalities in cardiac muscle mitochondrial oxidative capacity may be responsible for functional alterations of the heart during coronary atherosclerosis. Decreased oxidative capacities could be the basis for lower oxygen utilization and exercise capacity in heart failure.
